Bharat Biotech on Monday said it has begun the phase 3 clinical trials of its coronavirus disease (Covid-19) vaccine candidate, Covaxin, in India, with 26,000 participants across 22 sites in the country. The trial will be conducted in partnership with…
Read MoreIndia’s active Covid-19 cases declining steadily, says health ministry as caseload falls below 9 lakh-mark
As India’s tally of active novel coronavirus (Covid-19) cases fell below the nine lakh-mark, the Ministry of health and family welfare (MoHFW) on Friday highlighted this was the first time in exactly a month that the country’s active Covid-19 caseload…
Read More